Blood glucose monitoring systems

Security and Privacy for Implantable Medical Devices

Volumn 9781461416746, Issue , 2014, Pages 15-82

  Valgimigli, Francesco ^a   Mastrantonio, Fabrizio ^a   Lucarelli, Fausto ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; INTENSIVE CARE UNITS; MONITORING; PATIENT TREATMENT;

BLOOD GLUCOSE; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICES; CONTINUOUS GLUCOSE MONITORING; DIABETES MELLITUS; DYNAMIC ASSESSMENT; GLUCOSE CONTROL; GLUCOSE MONITORING SYSTEM; GLYCEMIC CONTROL; SELF-MONITORING;

GLUCOSE;

EID: 84937480879     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1674-6_2     Document Type: Chapter

References (85)

1. Wang J., 2008. Electrochemical glucose biosensors, Chem. Rev., 108, 814-825.
2. Reach. G.; Wilason G.S., 1992. Anal. Chem. 64, 381A.
3. P. D'Orazio, R.W. Burnett, N. Fogh-Andersen, E. Jacobs, K. Kuwa, W.R. Kulpmann, L. Larsson, A. Lewenstam, A.H.J. Maas, G. Mager, J.W. Naskalski, A.O. Okorodudu, 2005. Clin. Chem. 51, 1573-1576.
4. Frank M Brunkhorst and Hans G Wahl.Blood glucose measurements in the critically ill more than just a blood draw. Critical Care 2006, 10:178.
5. Kaplan L.A., Pesce A.J., Clinical Chemistry - Theory, analysis and correlation, 3rd Edition, 1996, Mosby-Year Book, Inc.
6. Price C. Point-of-care testing in diabetes mellitus. Clinic Chem Lab Med 41 1213-1219, 2003.
7. Tsuge, H., Natsuakai, O., and Ohashi, K. (1975). J. Biochem. 78, 835-843.
8. J. Raba and H.A. Mottola, 1995. Glucose oxidase as an analytical reagent. Critical Rev. Anal. Chem., 25, 1-42.
9. Swoboda, B. E. P. (1965) Biochim. Biophys. Acta 175, 365-369.
10. Tsujimura S., Kojima S., Kano K., Ikeda T., Sato M., Sanada H., Omura H., 2006. Novel FAD-dependent glucose dehydrogenase for a dioxygen-insensitive glucose biosensor. Biosci. Biotechnol. Biochem. 70, 654-659.
11. A. Heller and B. Feldman, 2008. Electrochemical Glucose Sensors and Their Applications in Diabetes Management. Chem. Rev. 108, 2482-2505.
12. Sode, K., Kojima, K., 1997. Improved substrate specificity and dynamic range for glucose measurement of Escherichia coli PQQ glucose dehydrogenase by site directed mutagenesis. Biotechnol. Lett. 19, 1073-1077.
13. J.G. Hauge, 1964. Glucose Dehydrogenase of Bacterium anitratum: an Enzyme with a Novel Prosthetic Group. J. Biol. Chem. 239, 3630-3639.
14. Karp G., Cell and Molecular Biology, 5th Ed., Wiley, 2008.
15. Loach P.A., 1976. In Handbook of Biochemistry and Molecular Biology, 3rd ed. (Fasman, G.D., ed.), Physical and Chemical Data, vol. 1, pp. 122-130, CRC Press, Boca Raton, FL.
16. Duine, J.A., Frank, J., van Zeeland, J.K., 1979. Glucose dehydrogenase from Acinetobacter calcoaceticus: a 'quinoprotein'. FEBS Lett. 108, 443-446.
17. Ling. Ye, Martin. Haemmerle, Arjen J. J. Olsthoorn, Wolfgang. Schuhmann, Hans Ludwig. Schmidt, Johannis A. Duine, Adam. Heller. High current density "wired" quinoprotein glucose dehydrogenase electrode. Anal. Chem., 1993, 65 (3), pp 238-241.
18. http://www.amano-enzyme.co.jp/pdf/wave-e/vol10/vol10e-p2.pdf
19. http://www.amano-enzyme.co.jp/pdf/wave-e/vol5/vol5-topic.pdf
20. Prof. L. Laffel, personal communication.
21. Nicolas Mano and Adam Heller. Detection of Glucose at 2 fM Concentration. Anal. Chem., 2005, 77, 729-732.
22. Tang Z, Du X, Louie RF, Kost GJ : Effects of drugs on glucose measurements with handheld glucose metes and a portable glucose analyser. Am J Clin Pathol 113: 75-86, 2000.
23. NCCLS Guideline EP7-P, Interference Testing in Clinical Chemistry.
24. Witt et al., 2000. Biochem. J. 347, 553-559.
25. Tang Z, Du X, Louie RF, Kost GJ : Effects of pH on glucose measurement with handheld glucose meters and portable glucose analyser for point-of-care testing. Arch Pathol Lab Med 124:577-582, 2000.
26. B. Innocenti, F. Mastrantonio, "POCT and connectivity: towards the laboratory without boundaries". Hospital Healthcare Europe, 2005/20 06, L15-L17
27. Maran A., Crepaldi C., Tiengo A., Grassi G., Vitali E., Pagano G., Bistoni S. et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 25: 347, 2002.
28. Wentholt I.M., Volle Bregt M.A., Hart A.A., Hoekstra J.B., DeVries J.H. Comparison of a needle-type and a microdialysis Continuous Glucose Monitoring in Type 1 Diabetic Patients. Diabetes Care 28: 2871, 2005.
29. Kovatchev B., Anderson S., Heinemann L., Clarke W. Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors. Diabetes Care 31: 1160, 2008.
30. Mello G., Parretti E., Tondi F., Bruno S., Iannuzzi L., DiCianni G., La polla A., Messeri D., Poscia A., Correlations between post-prandial glucose areas measured by continuous glucose monitoring (GlucoDay®) and fetal body composition in pregnant women with normal glucose tolerance. Am. J. Obstet. Gynecol. 193: S90, 2005.
31. De Block C., Keenoy B.M., VanGaal L., Rogiers P., Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care 29: 1750, 2006.
32. Van Den Berghe G.,Wouters P.,Weekers F., Verweast C. Intensive Insulin Therapy in Critically ill Patients. N. Engl. J. Med. 345: 1359, 2001.
33. Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., Van Wijngaerden E., Bobbaers H., Bouillon R. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354: 449, 2006.
34. Pfeiffer E.F., Thum C., Clemens A. The artificial beta cell. A continuous control of blood sugar by external regulation of insulin infusion. Horm. Metabol. Res. 6: 339, 1974.
35. Fogt E.J., Dodd L.M., Jenning E.M., Clemens A.H. Development and evaluation of a glucose analyzer for a glucose-controlled insulin infusion system (Biostator®). Clin. Chem. 24(8): 1366, 1978.
36. Keenan D.B., Cartaya R.,Mastrototaro J.J. Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm. J. Diabetes Sci. Technol. 4(1): 111, 2010.
37. Bode B., Gross K., Rikalo N., Schwartz S., Wahl T., Page C., Gross T., Mastrototaro J.J. Alarms based on real time sensor glucose values alert patients to hypo and hyper glycemia: the Guardian Continuous Monitoring System. Diabetes Technol. Ther. 6: 105, 2004.
38. Mastrototaro J.J., Shin J., Marcus A., Sulur G. The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes. Diabetes Technol. Ther. 10(5): 385, 2008.
39. Blevins T.C. Professional Continuous Glucose Monitoring in Clinical Practice 2010. J. Diabetes Sci. Technol. 4(2): 440, 2010.
40. Weinstein R.L., Bugler J.R., Schwartz S.L., Peyser T.A., Brazg R.L., McGarraugh G.V. Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System. Diabetes Care 30 (5): 1125, 2007.
41. McGarraugh G., Bergenstal R. Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System. Diabetes Technol. Ther. 11(3): 145, 2009.
42. Garg S., Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 29(12): 2644, 2006.
43. Kamath A.,Mahalingham A., Brauker J. Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor. Diabetes Technol. Ther. 11(11): 689, 2009.
44. Poscia A., Mascini M., Moscone D., Luzzana M., Caramenti G., Cremonesi P., Valgimigli F., Bongiovanni C., Varalli M. A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1). Biosens. Bioelectron. 18: 891, 2003.
45. Varalli M., Marelli G., Maran A., Bistoni S., Luzzana M., Cremonesi P., Caramenti G., Valgimigli F., Poscia A. A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 2). Biosens. Bioelectron 18: 899, 2003.
46. De Block C., Vertommen J., Manuel-y-Keenoy B., Van Gaal L. Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects. Curr. Diabetes Rev. 4(3): 159, 2008.
47. Hermanns N., Kulzer B., Gulde C., Eberle H., Pradler E., Patzelt-Bath A., Haak T. Short-term effects on patient satisfaction of continuous glucose monitoring with the GlucoDay with realtime and retrospective access to glucose values: a crossover study. Diabetes Technol. Ther. 11(5): 275, 2009.
48. Anke Sieg, Richard H. Guy, M. Begoña Delgado-Charro: Non-invasive Glucose monitoring by reverse iontophoresis in vivo: Application of the internal standard concept. Clin. Chem. 50(8): 1383, 2004.
49. Wentholt I.M.E., Hoekstra J.B.L., Zwart A., DeVries J.H. Pendra goes Dutch: lessons for the CE mark in Europe. Diabetologia 48: 1055, 2005.
50. Valgimigli F., Lucarelli F., Scuffi C., Morandi S., Sposato I. Evaluating the clinical accuracy of GlucoMen®Day: a novel microdialysis-based continuous glucose monitor. J. Diabetes Sci. Technol. 4 (5): 1182, 2010.
51. Peyser T., Zisser H., Khan U., Jovanovic L., BevierW., Romey M., Suri J., Strasma P., Tiaden S. Gamsey S., Use of a novel fluorenscent glucose sensor in volunteer subjects with Type 1 Diabetes Mellitus J. Diabetes Sci. Technol. 5(3): 687, 2011.
52. Jax T., Heise T., Nosek L., Gable J., Lim G., Calentine C. Automated Near-Continuous Glucose Monitoring Measured in Plasma Using Mid-Infrared Spectroscopy J. Diabetes Sci. Technol. 5(2): 345, 2011.
53. Möller F., Liska J., Eidhagen F., Franco-Cereceda A. Intravascular Microdialysis as a Method for Measuring Glucose and Lactate during and after Cardiac Surgery J. Diabetes Sci. Technol. 5(5): 1099, 2011.
54. Lucarelli F., Ricci F., Caprio F., Valgimigli F., Scuffi C., Moscone D., Palleschi G. GlucoMen Day continuous glucose monitoring system: a screening for enzymatic and electrochemical interferents J. Diabetes Sci. Technol. 6(5): 1172, 2012.
55. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus, The Diabetes Control and Complications Trial (DCCT) Research Group, N Engl J Med 1993; 329
56. Sparacino G., Zanon M., Facchinetti A., Zecchin C.,Maran A. Cobelli C. Italian Contributions to the Development of Continuous Glucose Monitoring Sensors for Diabetes Management Sensors 2012, 12, 13753-13780
57. M.J. Rice, D.B. Coursin Continuous Measurement of Glucose - Facts and Challenges., Anesthesiology 116 (1), 199, 2012
58. J.-C. Preiser, The Future of Glucose Control in the ICU. ICU Management, 13 (1), 24. 2013
59. J.S. Krinsley et al., Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit. Care 17, R37, 2013.
60. Jeffrey I Joseph, D.O. Analysis: New Point-of-Care Blood Glucose Monitoring System for the Hospital Demonstrates Satisfactory Analytical Accuracy Using Blood from Critically Ill Patients-An Important Step toward Improved Blood Glucose Control in the Hospital Journal of Diabetes Science and Technology Volume 7, Issue 5, September 2013
61. J. Newman A, Turner Home blood glucose biosensors: a commercial perspective Biosensors & Bioelectronics (20) 2005 2435-2453
62. N.S. Oliver et al. Glucose sensors: a review of current and emerging technology Diabetic Medicine 2009 26, 197-210
63. D. Zahn et al. Novel device for quick measurement of glucose in POCT areas without preanalytical steps based on multi-way glucose biosensor, Eng. Life Sci. 2009, 9 n. 5, 398-403
64. Simon Finfer, Jan Wernerman, Jean-Charles Preiser, Tony Cass, Thomas Desaive, Roman Hovorka, Jeffrey I Joseph, Mikhail Kosiborod, James Krinsley MD, Iain Mackenzie, Dieter Mesotten, Marcus Schulz, Mitchell G. Scott, Robert Slingerland, Greet Van den Berghe, Tom Van Herpe, Consensus Recommendations on "Measurement of Blood Glucose and Reporting Glycemic Control in Critically Ill Adults" Critical Care 2013, 17: 229
65. Kaczmarek E, Guerra E, Mosca A, Mastrantonio F, Lucarelli F, Valgimigli F, Ceriotti F, "Comparative assessment of the performances of the StatStrip point-of-care testing device for the measurements of ketone bodies.", Biochimica Clinica, 2013, vol. 37, SS S683.
66. Rooyackers O., Blixt P, Wernerman J, "Continuos glucose monitoring by intravenous microdyalysis: influence of membrane length and dialysis flow-rate", Acta Anesthesiol.Scand., 2012
67. Tang Z, Louie R, Payes M, Chang K, Kost G: Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther 2000, 2:349-362
68. Tang Z, Du X, Louie R, Kost G: Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Arch Pathol Lab Med 2000, 124:577-582
69. Chance J, Li D, Jones K, Dyer K, Nichols J: Technical evaluation of five glucose meters with data management capabilities. Am J Clin Path 1999, 111:547-556
70. Louie R, Tang Z, Sutton D, Lee J, Kost G: Point-of-care glucose testing. Arch Pathol Lab Med 2000, 124:257-266
71. Tang Z, Lee J, Louie R, Kost G: Effects of different haematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med 2000, 124:1135-1140
72. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem 47: 209-14 (2001)
73. Mann E, Salinas J, Pidcoke H et al Error rates resulting from Anemia can be corrected in multiple commonly used point of care glucometers J Trauma 2008 64:15-21.
74. Krinsley J, Grover A. Severe hypoglycaemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35: 2262-2267
75. C.L.S.I., Point of care blood glucose testing in acute and chronic care facilities; approved guideline - Third edition. POCT12-A3. 2013. 33(2)
76. Karon B Griemann L Scott R et al Evaluation of the Impact of Haematocrit and Other Interference on the Accuracy of Hospital-Based Glucose Meters. Diabetes Technology & Therapeutics 2008 10, Number 2, 111-120
77. Holtzinger C Szelag, E. DuBois, et al. Evaluation of a New POCT Bedside Glucose Meter and Strip With Haematocrit and Interference Corrections Point of Care 2008 7, Number 1 1-6.
78. Hopf S, Graf, B., and Gruber, M Comparison of Point-of-Care Testing Glucose Results from Intensive Care Patients Measured with Network-Ready Devices, Diabetes Technology & TherapeuticsVolume 13, Number 10, 2011
79. International Organization for Standardization (ISO). In vitro diagnostic test systems. Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. International Standard ISO 15197:2013
80. Kovatchev et al. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care. 2004;27:1922-1928
81. Ellmerer et al. Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery. Diabetes Care. 2006;29(6):1275-1281.
82. The NICE-SUGAR Study Investigators. Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med 2009; 360:1283-1297
83. L. Heinemann et al. Reimbursement for Continuous Glucose Monitoring: A European View Journal of Diabetes Science and Technology Volume 6, Issue 6, November 2012
84. Mastrantonio F., Valgimigli F., Grassi L., Cappa P., De Micheli G., Carrara S., "Comparative Performance of Different Nanostructured Electrochemical Sensors on Insulin Detection" BioNanoSci., 2013 3:285-288
85. Brunner R, Kitzberger R, Miehsler W, Herkner H, Madl C, Holzinger U., Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med. 2011; 16:659-664